Back to Pediatrics
Pediatricsv2024Evidence-Based

Cornell Assessment of Pediatric Delirium (CAPD)

Screens for delirium in pediatric patients through behavioral assessment of awareness, cognition, and psychomotor symptoms.

Clinical Input Parameters

points
Range: 0 — 4 points
points
Range: 0 — 4 points
points
Range: 0 — 4 points
points
Range: 0 — 4 points
points
Range: 0 — 4 points
points
Range: 0 — 4 points
points
Range: 0 — 4 points
points
Range: 0 — 4 points
years
Range: 0 — 21 years
Clinical Assessment
Awaiting Parameters
capd assessment
—assessment
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Cornell Assessment of Pediatric Delirium (CAPD) is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within pediatrics.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Sum of all 8 domain scores (0-32 points). CAPD positive if total score ≥ 9 points

Clinical Pearls & Practice Notes

  • The CAPD is a validated tool for detecting delirium in pediatric patients aged 0-21 years
  • Based on behavioral observations during routine nursing care - no patient participation required
  • Can be completed in less than 2 minutes by bedside nurses
  • Applicable to both developmentally normal and delayed children
  • Sensitivity 94.1% and specificity varies by age group (highest in younger children)
  • Should be performed every nursing shift for all pediatric ICU patients
  • Cutoff score ≥9 optimizes sensitivity for delirium detection
  • Developmental anchor points help guide age-appropriate assessment
  • Excludes deeply sedated patients (RASS < -3)
  • Delirium prevalence in pediatric ICU patients is approximately 20-25%
  • Early detection allows for prompt intervention and improved outcomes
  • Part of comprehensive pediatric delirium screening and management protocols

Evidence & Literature Citations

  1. Traube C, Silver G, Kearney J, Patel A, Atkinson TM, Yoon MJ, et al. Cornell Assessment of Pediatric Delirium: a valid, rapid, observational tool for screening delirium in the PICU. Crit Care Med. 2014 Mar;42(3):656-63. doi: 10.1097/CCM.0b013e3182a66b76.
  2. Silver G, Traube C, Gerber LM, Sun X, Kearney J, Patel A, et al. Pediatric delirium and associated risk factors: a single-center prospective observational study. Pediatr Crit Care Med. 2015 May;16(4):303-9. doi: 10.1097/PCC.0000000000000356.
  3. Traube C, Silver G, Gerber LM, Kaur S, Mauer EA, Kerson A, et al. Delirium and mortality in critically ill children: epidemiology and outcomes of pediatric delirium. Crit Care Med. 2017 May;45(5):891-898. doi: 10.1097/CCM.0000000000002324.
  4. Smith HA, Boyd J, Fuchs DC, Melvin K, Berry P, Shintani A, et al. Diagnosing delirium in critically ill children: Validity and reliability of the Pediatric Confusion Assessment Method for the Intensive Care Unit. Crit Care Med. 2011 Jan;39(1):150-7. doi: 10.1097/CCM.0b013e3181feb489.

Score Interpretation Ranges

CAPD Negative0 – 8 pts

No delirium detected

CAPD Positive9 – 32 pts

Delirium present

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.